FDA Inspection 997995 — Nancy A. Krywonis, M.D.
The FDA completed an inspection of Nancy A. Krywonis, M.D. on December 6, 2016 in Denver, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 6, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Denver, CO (United States)
Additional Details
Clinical Investigator (CI)